HomeInsightsPE

Hikal Ltd PE Ratio

Hikal Ltd PE Ratio

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

14.7 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Hikal Ltd

NSE: HIKAL

PE

65.6

Last updated on: Nov 25, 2024

Key Highlights

  • The P/E Ratio of Hikal Ltd is 65.6 as of 25 Nov 15:30 PM .
  • The P/E Ratio of Hikal Ltd changed from 20.9 on March 2019 to 47 on March 2024 . This represents a CAGR of 14.46% over 6 years.
  • The Latest Trading Price of Hikal Ltd is ₹ 396.05 as of 25 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Hikal Ltd

No data available

Company Fundamentals for Hikal Ltd

No data available

Image

Hikal Ltd

NSE: HIKAL

Share Price

₹ 396.05

5.30 (1.36%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Hikal Ltd

1M

1Y

3Y

5Y

Monitoring Hikal Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 2024396.05
22 Nov 2024390.75
21 Nov 2024387.65
19 Nov 2024392.2
18 Nov 2024400.4
14 Nov 2024403.05
13 Nov 2024387.3
12 Nov 2024384.75
11 Nov 2024376.05
08 Nov 2024386.95

SWOT Analysis Of Hikal Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Hikal Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Hikal Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Hikal Ltd654,817
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Hikal Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Hikal Ltd

No data available

* All values are in crore

Historical Revenue of Hikal Ltd

No data available

* All values are in crore

Historical EBITDA of Hikal Ltd

No data available

* All values are in crore

Historical Net Profit of Hikal Ltd

No data available

* All values are in crore

Historical Dividend Payout of Hikal Ltd

No data available

* All values are in %

About Hikal Ltd

  • Hikal Limited, incorporated on July 08th, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals.
  • The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities.
  • Presently, it is operating in the crop protection and pharmaceuticals space. The Company has 5 manufacturing facilities across three states in India.
  • It supply products to customers across the globe in the US, Japan, Europe, Canada, South East Asia, LATAM, India and RoW. Apart from this, it specialize in manufacturing APIs and intermediates in pharmaceutical division.
  • Within pharmaceutical division, it offer human health and animal health products.

Hikal Ltd News Hub

News

Hikal consolidated net profit declines 26.09% in the June 2024 quarter

Net profit of Hikal declined 26.09% to Rs 5.10 crore in the quarter ended June 2024 as aga...

Read more

2024-08-01 00:00:00

News

Hikal AGM scheduled

Hikal announced that the Annual General Meeting (AGM) of the company will be held on 17 Se...

Read more

2024-08-23 00:00:00

News

Hikal to announce Quarterly Result

Hikal will hold a meeting of the Board of Directors of the Company on 12 November 2024 Pow...

Read more

2024-11-06 00:00:00

News

Hikal consolidated net profit rises 45.58% in the September 2024 quarter

Net profit of Hikal rose 45.58% to Rs 18.30 crore in the quarter ended September 2024 as a...

Read more

2024-11-12 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Hikal Ltd

What is the current PE Ratio of Hikal Ltd?

The Current PE Ratio of Hikal Ltd is 65.56 as on 25 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 25 Nov 2024.

What was the PE Ratio of Hikal Ltd last year?

The PE Ratio of Hikal Ltd was 44.32 last year, now the PE ratio is 65.56, showing a year-on-year growth of 47.9%.

What does the PE Ratio of Hikal Ltd indicate about its stock?

The PE Ratio of Hikal Ltd is 65.56. This ratio indicates that investors are willing to pay 65.56 times the earnings per share for each share of Hikal Ltd.

What is the PE Ratio Growth of Hikal Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Hikal Ltd grew by 47.9% whereas, the EPS ratio grew by 261.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*